324
Views
1
CrossRef citations to date
0
Altmetric
Diabetes

Biphasic insulin aspart 30 treatment for people with type 2 diabetes: a budget impact analysis based in Thailand

, , &
Pages 369-375 | Received 23 Sep 2017, Accepted 23 Nov 2017, Published online: 08 Dec 2017

References

  • Davidson JA, Liebl A, Christiansen JS, et al. Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis. Clin Ther 2009;31:1641-51
  • Cucinotta D, Russo GT. Biphasic insulin aspart in the treatment of type 2 diabetes mellitus. Expert Opin Pharmacother 2009;10:2905-11
  • Fidler C, Elmelund Christensen T, Gillard S. Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econ 2011;14:646-55
  • Deerochanawong C, Ferrario A. Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Global Health 2013;9:11
  • Thai National Drug Development Committee. The National List of Essential Medicine. Bangkok: TNDDC; 2016. Available online at: http://drug.fda.moph.go.th:81/nlem.in.th/. [Last accessed 20 February 2017]
  • Teerawattananon Y, Tritasavit N, Suchonwanich N, et al. The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand. Z Evid Fortbild Qual Gesundhwesen 2014;108:397-404
  • Rangsin R, MedResNet. An assessment on quality of care among patients diagnosed with type 2 diabetes and hypertension visiting hospitals of Ministry of Public Health and Bangkok Metropolitan Administration in Thailand, 2014. Bangkok, Thailand: National Health Security Office (NHSO); 2014
  • Leelahavarong P. Budget impact analysis. J Med Assoc Thai 2014;97(Suppl5):S65-S71
  • Tan SC, Matzen P, Yeo LN. Budget impact analysis of biphasic insulin aspart in the treatment of type 2 diabetes mellitus in Malaysia: a public payer perspective. Value Health 2014;17:A743
  • Tan SC, Matzen P, Khoo SP. Budget impact analysis of wider adoption of biphasic insulin aspart (BIAsp) in the treatment of type 2 diabetes mellitus (T2DM): a perspective of patients treated by public providers in Singapore. Value Health 2014;17:A743
  • Rangsin R, Tatsanavivat P, MedResNet. An assessment on quality of care among patients diagnosed with type 2 diabetes and hypertension visiting hospitals of Ministry of Public Health and Bangkok Metropolitan Administration in Thailand, 2012. Bangkok, Thailand: National Health Security Office (NHSO); 2012
  • Official Statistics Registration Systems. Thai population. Bangkok: OSRS; 2016. Available online at: http://stat.dopa.go.th/stat/statnew/upstat_age_disp.php. [Last accessed 20 February 2017]
  • Aekplakorn W, Thai National Health Examination Survey V Study Group. Thai National Health Examination Survey, NHES V. Nonthaburi, Thailand: National Health Examination Survey Office, Health System Research Institute; 2016
  • Aekplakorn W, Chariyalertsak S, Kessomboon P, et al. Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009. Diabetes Care 2011;34:1980-5
  • Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S, et al. Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage. J Med Assoc Thai 2006;89(Supp1):S66-S71
  • Permsuwan U, Chaiyakunapruk N, Dilokthornsakul P, et al. Long-term cost-effectiveness of insulin glargine versus neutral protamine hagedorn insulin for type 2 diabetes in Thailand. Appl Health Econ Health Policy 2016;14:281-92
  • Halimi S, Raskin P, Liebl A, et al. Efficacy of biphasic insulin aspart in patients with type 2 diabetes. Clin Ther 2005;27(SupplB):S57-S74
  • Rawdaree P, Sarinnapakorn V, Pattanaungkul S, et al. A prospective, longitudinal, multicenter, observational study to assess insulin treatment patterns in diabetic patients in Thailand: results from the TITAN study. J Med Assoc Thai 2014;97:1140-50
  • Drug and Medical Supply Information Center; 2017. Ministry of Public Health, Nonthaburi; Available online at: http://dmsic.moph.go.th. [Last accessed 21 February 2017]
  • Riewpaiboon A. Measurement of costs for health economic evaluation. J Med Assoc Thai 2014;97(Suppl5):S17-S26
  • Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health 2007;10:61-72
  • Thai Nephrology Society of Thailand. Thailand renal replacement therapy year 2014. Bangkok: Thai Nephrology Society of Thailand; 2014
  • Riewpaiboon A. Standard cost lists for health technology assessment: Health Intervention and Technology Assessment Program (HITAP); 2011; Nonthaburi
  • Bureau of Trade and Economics Indices, Ministry of Commerce. CPI; 2017. Bangkok; Available online at: http://www.price.moc.go.th/default5.aspx. [Last accessed 3 March 2017]
  • Bank of Thailand. Rates of exchange of commercial banks in Bangkok metropolis (2002–present). Bangkok: Bank of Thailand; 2017. Available online at: http://www2.bot.or.th/statistics/ReportPage.aspx?reportID=123&language=eng. [Last accessed 21 April 2016]
  • IMS Diabetes Market. Bangkok: MAT Dec 2016; 2016
  • Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) outcomes model (UKPDS no. 68). Diabetologia 2004;47:1747-59
  • Bureau of Policy and Strategy. Public health statistics A.D. 2015. Office of the Permanent Secretary, Nonthaburi: Ministry of Public Health; 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.